Poly thymidine polymorphism and cystic fibrosis in a non-Caucasian population

Disease Markers

Volumn 32, Issue 4, 2012, Pages 241-246

  Tabaripour, Reza ^a   Niaki, Haleh Akhavan ^b   Douki, Mohammad Reza Esmaeeli ^b   Bazzaz, Javad Tavakkoly ^c   Larijani, Bagher ^c   Yaghmaei, Parichehr ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cystic fibrosis; Iran; IVS8 polyT; p.Phe508del; polymorphism

Indexed keywords

POLY THYMIDINE; THYMIDINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; IRAN; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 84859314855     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0880     Document Type: Article

References (39)

1. Rommens JM, Iannuzzi MC, Kerem B et al. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065. (Pubitemid 19231813)
2. Riordan JR, Rommens JM, Kerem B et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073. (Pubitemid 19231814)
3. Kerem B, Rommens JM, Buchanan JA et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080. (Pubitemid 19231815)
4. McCarthy VA, Harris A (2005) The CFTR gene and regulation of it's expression. Pediatr Pulmonol 40:1-8. (Pubitemid 40917901)
5. Zielenski J, Rozmahel R, Bozon Det al. (1991) Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10:214-228.
6. Reisin IL, Prat AG, Abraham EH et al. (1994) Cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 269:20584-20591. (Pubitemid 24260468)
7. Schwiebert EM, Egan ME, Hwang TH et al. (1995) CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81:1063-1073.
8. Stutts MJ, Canessa CM, Olsen JC et al. (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science 269:847-850.
9. Vankeerberghen A, Cuppens H, Cassiman J-J (2002) The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst Fibros 1:13-29.
10. Mehta A (2005) CFTR: more than just a chloride channel. J Pediatr Pulmonol 39:292-298.
11. Rosenstein BJ, Zeitlin PL (1998) Cystic fibrosis. Lancet 351:277-82. (Pubitemid 28043961)
12. Farrell PM, Rosenstein BJ, White TB et al. (2008) Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report. J Pediatr 153:S4-S14. (Pubitemid 351970581)
13. Welsh MJ, Fick RB (1987) Cystic fibrosis. J Clin Invest 80:1523-1526. (Pubitemid 18007121)
14. Elahi E, Khodadad A, Kupershmidt I et al. (2006) A haplo-type framework for cystic fibrosis mutations in Iran. J Mol Diagnostics 8:119-127. (Pubitemid 43257443)
15. Kambouris M, Banjar H, Moggari I et al. (2000) Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations. Eur J Pediatr 159:303-309. (Pubitemid 30243630)
16. Eskandarani HA (2002) Cystic fibrosis transmembrane regulator gene mutations in Bahrain. J Trop Pediatr 48:348-350.
17. Ashavaid TF, Kondkar AA, Dherai AJ et al. (2005) Application of Multiplex ARMS and SSCP/HD Analysis in Molecular Diagnosis of Cystic Fibrosis in Indian Patients. Mol Diagn 9:59-66. (Pubitemid 43066359)
18. Jalalirad M, Houshmand M, Mirfakhraie R et al. (2004) First study of CF mutations in the CFTR gene of Iranian patients: detection of DeltaF508, G542X, W1282X, A120T, R117H, and R347H mutations. J Trop Pediatr 50:359-361. (Pubitemid 40017229)
19. Yilmaz E, Erdem H, Ozguc M et al. (1995) Study of 12 mutations in Turkish cystic fibrosis patients. Human Heredity 45:175-177.
20. Alibakhshi R, Kianishirazi R, Cassiman JJ et al. (2008) Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J Cyst Fibros 7:102-9. (Pubitemid 351384304)
21. Dequeker E, Stuhrmann M, Morris MA et al. (2009) Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders - updated European recommendations. Eur J Hum Genet 17:51-65.
22. Moutou C, GardesN and Viville S (2002) Multiplex PCR combining deltaF508 mutation and intragenic microsatellites of the CFTR gene for pre-implantation genetic diagnosis (PGD) of cystic fibrosis. Eur J Hum Genet 10:231-238. (Pubitemid 34662090)
23. Elce A, Boccia A, Cardillo G et al. (2009) Three Novel CFTR Polymorphic Repeats Improve Segregation Analysis for Cystic Fibrosis. Clin Chem 55:1372-1379.
24. Niksic M, Romano M, Buratti E et al. (1999) Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet 8:2339-2349.
25. Radpour R, Gilani MA, Gourabi H et al. (2006) Molecular analysis of the IVS8-T splice variant 5T and M470V exon 10 missense polymorphism in Iranian males with congenital bilateral absence of the vas deferens. Mol Hum Reprod 12:469- 473.
26. Kosova G, Pickrell JK, Kelley JL et al. (2010) The CFTR Met 470 allele is associated with lower birth rates in fertile men from a population isolate. PLoS Genet 6:e1000974.
27. Chiang HS, Lu JF, Liu CH et al. (2009) CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. Clin Genet 76:282- 286.
28. Grangeia A, Niel F, Carvalho F et al. (2004) Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens. Hum Reprod 19:2502-2508. (Pubitemid 39481274)
29. Huber K, Mirkovic B, Nersesian R et al. (2002) Survey of CF mutations in the clinical laboratory. BMC Clin Pathol 2:4-11.
30. Huang Q, Ding W, Wei MX (2008) Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population. World J Gastroenterol 14:1925-1930. (Pubitemid 351523826)
31. Desgeorges M, Mégarbané A, Guittard C et al. (1997) Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities. Hum Genet 100:279-283. (Pubitemid 27338805)
32. Lappin S, Cahlik J, Gold B (2001) Robot Printing of Reverse Dot Blot Arrays for Human Mutation Detection. J Mol Diagn 3:178-188. (Pubitemid 33100339)
33. Morea1 A, Cameran M, Rebuffi AG et al. (2005) Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility. Mol Hum Reprod 11:607-614.
34. Cuppens H, Teng H, Raeymaekers P et al. (1994) CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet 3:607-614. (Pubitemid 24122175)
35. Groman JD, Hefferon TW, Casals T et al. (2004) Variation in a Repeat Sequence Determines Whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Is Pathogenic or Benign. Am J Hum Genet 74:176-179. (Pubitemid 38085249)
36. Esmaeili Dooki MR, Akhavan-Niaki H and Ghabeli Juibary A (2011) Detecting Common CFTR Mutations by Reverse Dot Blot Hybridization Method in Cystic Fibrosis - First Report from Northern Iran. Iran J Pediatr 21:51-57.
37. Radpour R, Taherzadeh-Fard E, Gourabi H et al. (2009) Novel cause of hereditary obstructive azoospermia: a T2 allele in the CFTR gene. Reprod Biomed 18:327-32.
38. Disset A, Michot C, Harris A et al. (2005) T3 Allele in the CFTR Gene Exacerbates Exon 9 Skipping in Vas Deferens and Epididymal Cell Lines and Is Associated With Congenital Bilateral Absence of Vas Deferens (CBAVD). Hum Mut 25:72- 81.
39. Viel M, Leroy C, Des Georges M et al. (2005) Novel length variant of the polypyrimidine tract within the splice acceptor site in intron 8 of the CFTR gene: consequences for genetic testing using standard assays. Eur J Hum Genet 13:136-138. (Pubitemid 40220555)